Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)

Abrahão Fontes Baptista, Ana Mércia B.L. Fernandes, Katia Nunes Sá, Alexandre Hideki Okano, André Russowsky Brunoni, Argelia Lara-Solares, Aziza Jreige Iskandar, Carlos Guerrero, César Amescua-García, Durval Campos Kraychete, Egas Caparelli-Daquer, Elias Atencio, Fabián Piedimonte, Frantz Colimon, Fuad Ahmed Hazime, João Batista S. Garcia, John Jairo Hernández-Castro, José Alberto Flores Cantisani, Kátia Karina Do Monte-Silva, Luis Claudio Lemos Correia & 15 others Manuel Sempértegui Gallegos, Marco Antonio Marcolin, María Antonieta Ricco, María Berenguel Cook, Patricia Bonilla, Pedro Schestatsky, Ricardo Galhardoni, Valquíria Silva, William Delgado Barrera, Wolnei Caumo, Didier Bouhassira, Lucy S. Chipchase, Jean Pascal Lefaucheur, Manoel Jacobsen Teixeira, Daniel Ciampi De Andrade

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.

Original languageEnglish
Pages (from-to)1-20
Number of pages20
JournalPain Reports
Volume4
Issue number1
DOIs
Publication statusPublished - 2019

Fingerprint

Pain Management
Chronic Pain
Consensus
Central Nervous System
Transcranial Magnetic Stimulation
Fibromyalgia
Migraine Disorders
Neuralgia
Complex Regional Pain Syndromes
Pain
Musculoskeletal Pain
Pain Threshold
Motor Cortex
Brain
Low Back Pain
Prefrontal Cortex
Abdominal Pain
Analgesics
Transcranial Direct Current Stimulation
Decision Making

Cite this

Baptista, A. F., Fernandes, A. M. B. L., Sá, K. N., Okano, A. H., Brunoni, A. R., Lara-Solares, A., ... De Andrade, D. C. (2019). Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP). Pain Reports, 4(1), 1-20. https://doi.org/10.1097/PR9.0000000000000692
Baptista, Abrahão Fontes ; Fernandes, Ana Mércia B.L. ; Sá, Katia Nunes ; Okano, Alexandre Hideki ; Brunoni, André Russowsky ; Lara-Solares, Argelia ; Iskandar, Aziza Jreige ; Guerrero, Carlos ; Amescua-García, César ; Kraychete, Durval Campos ; Caparelli-Daquer, Egas ; Atencio, Elias ; Piedimonte, Fabián ; Colimon, Frantz ; Hazime, Fuad Ahmed ; Garcia, João Batista S. ; Hernández-Castro, John Jairo ; Cantisani, José Alberto Flores ; Do Monte-Silva, Kátia Karina ; Correia, Luis Claudio Lemos ; Gallegos, Manuel Sempértegui ; Marcolin, Marco Antonio ; Ricco, María Antonieta ; Cook, María Berenguel ; Bonilla, Patricia ; Schestatsky, Pedro ; Galhardoni, Ricardo ; Silva, Valquíria ; Barrera, William Delgado ; Caumo, Wolnei ; Bouhassira, Didier ; Chipchase, Lucy S. ; Lefaucheur, Jean Pascal ; Teixeira, Manoel Jacobsen ; De Andrade, Daniel Ciampi. / Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP). In: Pain Reports. 2019 ; Vol. 4, No. 1. pp. 1-20.
@article{707915304c3d42af8539462e3ffe3400,
title = "Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)",
abstract = "Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.",
keywords = "Mixed pain, Neuropathic pain, Nociceptive pain, RTMS, TDCS",
author = "Baptista, {Abrah{\~a}o Fontes} and Fernandes, {Ana M{\'e}rcia B.L.} and S{\'a}, {Katia Nunes} and Okano, {Alexandre Hideki} and Brunoni, {Andr{\'e} Russowsky} and Argelia Lara-Solares and Iskandar, {Aziza Jreige} and Carlos Guerrero and C{\'e}sar Amescua-Garc{\'i}a and Kraychete, {Durval Campos} and Egas Caparelli-Daquer and Elias Atencio and Fabi{\'a}n Piedimonte and Frantz Colimon and Hazime, {Fuad Ahmed} and Garcia, {Jo{\~a}o Batista S.} and Hern{\'a}ndez-Castro, {John Jairo} and Cantisani, {Jos{\'e} Alberto Flores} and {Do Monte-Silva}, {K{\'a}tia Karina} and Correia, {Luis Claudio Lemos} and Gallegos, {Manuel Semp{\'e}rtegui} and Marcolin, {Marco Antonio} and Ricco, {Mar{\'i}a Antonieta} and Cook, {Mar{\'i}a Berenguel} and Patricia Bonilla and Pedro Schestatsky and Ricardo Galhardoni and Valqu{\'i}ria Silva and Barrera, {William Delgado} and Wolnei Caumo and Didier Bouhassira and Chipchase, {Lucy S.} and Lefaucheur, {Jean Pascal} and Teixeira, {Manoel Jacobsen} and {De Andrade}, {Daniel Ciampi}",
year = "2019",
doi = "10.1097/PR9.0000000000000692",
language = "English",
volume = "4",
pages = "1--20",
journal = "Pain Reports",
issn = "2471-2531",
number = "1",

}

Baptista, AF, Fernandes, AMBL, Sá, KN, Okano, AH, Brunoni, AR, Lara-Solares, A, Iskandar, AJ, Guerrero, C, Amescua-García, C, Kraychete, DC, Caparelli-Daquer, E, Atencio, E, Piedimonte, F, Colimon, F, Hazime, FA, Garcia, JBS, Hernández-Castro, JJ, Cantisani, JAF, Do Monte-Silva, KK, Correia, LCL, Gallegos, MS, Marcolin, MA, Ricco, MA, Cook, MB, Bonilla, P, Schestatsky, P, Galhardoni, R, Silva, V, Barrera, WD, Caumo, W, Bouhassira, D, Chipchase, LS, Lefaucheur, JP, Teixeira, MJ & De Andrade, DC 2019, 'Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)', Pain Reports, vol. 4, no. 1, pp. 1-20. https://doi.org/10.1097/PR9.0000000000000692

Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP). / Baptista, Abrahão Fontes; Fernandes, Ana Mércia B.L.; Sá, Katia Nunes; Okano, Alexandre Hideki; Brunoni, André Russowsky; Lara-Solares, Argelia; Iskandar, Aziza Jreige; Guerrero, Carlos; Amescua-García, César; Kraychete, Durval Campos; Caparelli-Daquer, Egas; Atencio, Elias; Piedimonte, Fabián; Colimon, Frantz; Hazime, Fuad Ahmed; Garcia, João Batista S.; Hernández-Castro, John Jairo; Cantisani, José Alberto Flores; Do Monte-Silva, Kátia Karina; Correia, Luis Claudio Lemos; Gallegos, Manuel Sempértegui; Marcolin, Marco Antonio; Ricco, María Antonieta; Cook, María Berenguel; Bonilla, Patricia; Schestatsky, Pedro; Galhardoni, Ricardo; Silva, Valquíria; Barrera, William Delgado; Caumo, Wolnei; Bouhassira, Didier; Chipchase, Lucy S.; Lefaucheur, Jean Pascal; Teixeira, Manoel Jacobsen; De Andrade, Daniel Ciampi.

In: Pain Reports, Vol. 4, No. 1, 2019, p. 1-20.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)

AU - Baptista, Abrahão Fontes

AU - Fernandes, Ana Mércia B.L.

AU - Sá, Katia Nunes

AU - Okano, Alexandre Hideki

AU - Brunoni, André Russowsky

AU - Lara-Solares, Argelia

AU - Iskandar, Aziza Jreige

AU - Guerrero, Carlos

AU - Amescua-García, César

AU - Kraychete, Durval Campos

AU - Caparelli-Daquer, Egas

AU - Atencio, Elias

AU - Piedimonte, Fabián

AU - Colimon, Frantz

AU - Hazime, Fuad Ahmed

AU - Garcia, João Batista S.

AU - Hernández-Castro, John Jairo

AU - Cantisani, José Alberto Flores

AU - Do Monte-Silva, Kátia Karina

AU - Correia, Luis Claudio Lemos

AU - Gallegos, Manuel Sempértegui

AU - Marcolin, Marco Antonio

AU - Ricco, María Antonieta

AU - Cook, María Berenguel

AU - Bonilla, Patricia

AU - Schestatsky, Pedro

AU - Galhardoni, Ricardo

AU - Silva, Valquíria

AU - Barrera, William Delgado

AU - Caumo, Wolnei

AU - Bouhassira, Didier

AU - Chipchase, Lucy S.

AU - Lefaucheur, Jean Pascal

AU - Teixeira, Manoel Jacobsen

AU - De Andrade, Daniel Ciampi

PY - 2019

Y1 - 2019

N2 - Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.

AB - Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.

KW - Mixed pain

KW - Neuropathic pain

KW - Nociceptive pain

KW - RTMS

KW - TDCS

UR - http://www.scopus.com/inward/record.url?scp=85061476557&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/latin-american-caribbean-consensus-noninvasive-central-nervous-system-neuromodulation-chronic-pain-m

U2 - 10.1097/PR9.0000000000000692

DO - 10.1097/PR9.0000000000000692

M3 - Article

VL - 4

SP - 1

EP - 20

JO - Pain Reports

JF - Pain Reports

SN - 2471-2531

IS - 1

ER -